Unknown OBSERVATIONAL NCT03824548

Outcomes for Patients With Gastro-Esophageal Reflux Disease

Real-World Analysis on the Diagnosis, Treatment Pattern and Outcomes for Patients With Gastro-Esophageal Reflux Disease (GERD) in China

Sponsor: Tianjin Happy Life Technology Co., Ltd.

Conditions Gastro-esophageal Reflux Disease

Interventions this is non-intervention study, there is no intervention drug or device in this study.

Updated 5 times since 2019 Last updated: Jan 29, 2019 Started: Jan 17, 2019 Primary completion: May 1, 2019 Completion: May 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Gastro-esophageal Reflux Disease, this trial is ongoing. The trial is conducted by Tianjin Happy Life Technology Co., Ltd. and has accumulated 5 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Feb 2021 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Feb 2021 [monthly]

Recruiting
Feb 2019 — Jan 2021 [monthly]

Recruiting

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tianjin Happy Life Technology Co., Ltd.

Data source: Tianjin Happy Life Technology Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China